Interferon Therapy Speeds Up Recovery From COVID-19

May 26, 2020 by Christen Aldrich

Filed under COVID-19 for Employers, COVID-19 for the Workforce

Last modified May 27, 2020

According to an exploratory study conducted in Wuhan, China and explained in this article by Medscape, treatment with the antiviral interferon alfa-2b (IFN-a2b) appears to speed up virus recovery and lower levels of key inflammatory markers in patients with COVID-19.

This study provides “the first compelling evidence of a potential treatment that is approved and we have decades of experience with,” said Dr. Eleanor Fish of the Toronto General Hospital Research Institute and the University of Toronto Department of Immunology.

She and her colleagues have previously demonstrated the therapeutic benefit of interferon during the Toronto SARS outbreak of 2002 and 2003. In that study, IFN treatment seemed to speed up the resolution of lung abnormalities in SARS-infected patients as well.

Share this

Related Articles

                                Leave a Comment